PharmaCord LLC (“PharmaCord” or the “Company”), a leading provider of patient services and commercialization solutions to life sciences companies, announces that funds advised by Permira, the global investment firm, have successfully completed their investment in PharmaCord. As a patient services provider, PharmaCord works on behalf of drug manufacturers to simplify the patient therapeutic journey. Through a combination of its proprietary PharmaCord Lynk™ technology suite, exceptionally talented team members and its non-commercial pharmacy PharmaCord Scripts™, PharmaCord helps patients have a better experience accessing and adhering to their critical medications.
Read the full article: PharmaCord Announces Completion of Permira Investment //
Source: https://www.accesswire.com/923264/pharmacord-announces-completion-of-permira-investment